Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19117,137,1.13 [0.85-1.52],0.4044208815599998
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19941,153,1.04 [0.77-1.39],0.8102376466963821
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19739,1136,1.13 [1.02-1.25],0.022563812178893
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19953,293,1.01 [0.81-1.25],0.923422475101242
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19365,2824,1.08 [1.01-1.16],0.0270376184807713
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19355,2864,1.15 [1.08-1.23],3.291978965453079e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19776,852,1.07 [0.94-1.21],0.3098079842056632
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19894,66,1.09 [0.70-1.69],0.7022412849480999
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18104,885,1.15 [1.01-1.29],0.0279810742843446
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17451,972,1.22 [1.09-1.37],0.0005203720886314
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17280,196,1.16 [0.89-1.50],0.2766635276347629
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14022,1852,1.15 [1.06-1.25],0.0007704150624161
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17224,326,1.25 [1.03-1.52],0.0254540735301121
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19944,1020,1.07 [0.96-1.20],0.2364617328683494
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,20027,367,1.01 [0.83-1.22],0.9191890868732346
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19318,715,1.22 [1.08-1.38],0.0013580181036987
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19963,983,1.11 [0.99-1.24],0.0716062687610458
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19079,155,1.04 [0.78-1.39],0.7703881774960163
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20062,42,0.80 [0.43-1.47],0.4700697943289589
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19831,851,1.10 [0.98-1.25],0.1061811389162826
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19882,54,0.88 [0.53-1.47],0.6191392426984914
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20002,98,1.29 [0.94-1.77],0.1132765175655617
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19987,83,1.24 [0.86-1.78],0.2434479374951846
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18992,389,1.01 [0.84-1.21],0.93085018661954
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18834,231,1.02 [0.81-1.29],0.8568246371682813
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18992,68,1.46 [1.03-2.07],0.0329491212537962
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20045,58,1.08 [0.67-1.72],0.7620220474774196
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20014,121,0.92 [0.65-1.31],0.6561820958562754
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral warts,19938,45,0.87 [0.49-1.55],0.6309185032395066
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19938,45,1.17 [0.69-1.98],0.5530323114535937
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,19803,292,1.12 [0.91-1.38],0.304269719394715
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20003,42,1.35 [0.81-2.24],0.2490099927440904
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19970,47,0.93 [0.53-1.63],0.7877456305482301
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20024,102,1.09 [0.77-1.57],0.6203155400060564
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19743,1374,1.02 [0.92-1.13],0.7051798356245724
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of meninges,20061,26,1.07 [0.53-2.16],0.850784971247482
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20011,56,1.62 [1.14-2.31],0.0076007514011327
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20049,64,0.95 [0.60-1.52],0.8379016655790897
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20039,380,1.18 [1.00-1.41],0.0562057004617707
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Caecum,20042,287,1.07 [0.87-1.33],0.5233541052054311
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19951,63,0.84 [0.51-1.36],0.470301224946237
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Descending colon,20036,240,1.22 [0.98-1.52],0.0758495015124169
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,19998,349,0.84 [0.68-1.04],0.1101663928280225
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19957,629,1.02 [0.88-1.18],0.7693727488784432
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20025,465,1.06 [0.90-1.25],0.4935114406135747
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15635,64,0.62 [0.37-1.03],0.0670969812890459
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15633,62,0.87 [0.53-1.44],0.5946523695239094
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20034,80,0.95 [0.62-1.45],0.8168792607425563
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",20034,77,0.95 [0.61-1.45],0.7982227595090374
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lung cancer and mesothelioma,13377,301,1.12 [0.89-1.41],0.321433427135356
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lymphoid leukaemia,15629,58,0.63 [0.37-1.07],0.0897597735590139
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15729,158,1.07 [0.80-1.42],0.6551182534569624
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15806,235,1.20 [0.96-1.49],0.1058263197574114
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15646,75,0.82 [0.52-1.29],0.3942836062500988
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15686,115,1.56 [1.22-2.00],0.0003431407752393
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15698,127,1.09 [0.79-1.50],0.5952865445031246
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15638,67,0.71 [0.43-1.15],0.1638322535842262
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16714,1143,1.17 [1.06-1.29],0.0026765861466351
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15692,121,0.80 [0.55-1.15],0.2194980047823439
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15664,93,0.93 [0.62-1.38],0.7107647243486456
RLN2,Prorelaxin H2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15674,103,1.32 [0.96-1.81],0.085127041518843
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,19961,142,0.80 [0.57-1.12],0.1919479081253883
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of trunk,20036,83,0.71 [0.45-1.10],0.1213581422734044
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanoma in situ,15599,63,0.90 [0.55-1.46],0.6600762436941341
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15660,89,0.87 [0.57-1.31],0.5044005051741975
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15713,142,1.00 [0.73-1.37],0.9854229496443614
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15765,194,1.04 [0.80-1.37],0.7503385482646074
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15659,88,1.07 [0.73-1.56],0.7376672980928631
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,19954,123,1.40 [1.06-1.85],0.0172930058942246
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16574,1003,0.94 [0.83-1.06],0.2778675385507448
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16634,1063,0.95 [0.84-1.06],0.3560557035357368
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19840,244,0.96 [0.75-1.22],0.7129694154563566
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18641,65,1.78 [1.38-2.29],8.483689242901454e-06
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19652,56,0.93 [0.56-1.54],0.7753237728636883
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19622,2265,1.05 [0.97-1.13],0.2583339786008483
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19032,50,1.28 [0.81-2.02],0.296507691402052
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19710,43,1.32 [0.82-2.14],0.2550675808196959
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19770,1194,1.06 [0.95-1.17],0.2857177885721997
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19768,1192,1.06 [0.95-1.17],0.3099928945905037
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18652,76,0.76 [0.48-1.20],0.2360660660909918
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19880,898,1.12 [1.00-1.26],0.0514778187200433
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19757,90,1.28 [0.90-1.81],0.170701168532568
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19653,57,1.16 [0.74-1.81],0.5201655009876018
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19649,53,0.86 [0.51-1.47],0.5886024591374073
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19925,258,1.11 [0.89-1.38],0.3579151438869157
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19982,38,1.07 [0.58-1.95],0.8310020127160627
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19876,209,1.02 [0.79-1.31],0.8887301430784018
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19043,61,0.80 [0.48-1.31],0.371836063262651
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14877,300,1.07 [0.87-1.32],0.4982652626898316
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18347,131,0.73 [0.52-1.04],0.0817918357455761
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18377,161,0.68 [0.50-0.93],0.0142936636107112
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14628,51,1.45 [0.94-2.24],0.0938915870587755
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18943,54,1.02 [0.61-1.71],0.9388813685745906
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18295,185,0.89 [0.67-1.19],0.4392465032318832
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19673,471,0.91 [0.77-1.09],0.3170649736877698
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19397,195,0.71 [0.53-0.94],0.0189531128666671
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19320,118,0.79 [0.55-1.14],0.2020915455323571
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19814,925,1.11 [0.99-1.25],0.0853519493151341
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17212,891,1.07 [0.95-1.21],0.286545951030014
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14635,58,1.17 [0.74-1.85],0.5045354412122843
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19348,36,0.60 [0.31-1.18],0.1390022327745339
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14790,213,1.05 [0.82-1.36],0.6957283792777819
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14636,59,1.43 [0.94-2.17],0.0932103042850091
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17787,3210,1.03 [0.96-1.10],0.4126683763995011
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14726,149,0.68 [0.49-0.95],0.0222898036862695
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15026,449,0.90 [0.75-1.08],0.2486918905526976
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20013,221,1.16 [0.92-1.46],0.1986805771440077
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19862,70,1.96 [1.56-2.47],1.1275625513452537e-08
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14701,124,0.70 [0.49-1.01],0.0559923849181494
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14632,55,1.05 [0.65-1.70],0.8479606228906086
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19908,596,1.19 [1.03-1.37],0.0149558429234278
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14829,252,1.43 [1.18-1.74],0.0002681512290976
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14863,286,1.34 [1.11-1.62],0.0022801024651531
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15175,598,1.07 [0.92-1.24],0.3810460073110958
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14689,112,1.30 [0.95-1.77],0.1003643776512339
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19856,64,2.03 [1.61-2.55],2.179173635743094e-09
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15064,487,0.89 [0.75-1.06],0.1942400090919989
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14903,326,0.91 [0.73-1.12],0.3771650502634417
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18158,48,0.70 [0.39-1.25],0.2220987909178683
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18896,4319,1.03 [0.98-1.09],0.2799440701025047
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19324,12,1.77 [0.92-3.40],0.085716376957876
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19333,21,1.64 [0.96-2.78],0.0681148979148819
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19926,1485,1.05 [0.95-1.15],0.3168267624633327
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19922,1480,1.05 [0.96-1.16],0.3033370121888836
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19326,14,2.06 [1.18-3.56],0.0103589543580505
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19838,669,1.00 [0.86-1.16],0.9977631590482344
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15914,1337,1.05 [0.95-1.16],0.3048971078028217
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20053,198,1.08 [0.85-1.36],0.5364745013846801
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19286,84,0.74 [0.48-1.14],0.1728737064355139
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19231,62,0.95 [0.59-1.54],0.8381822151142506
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19242,73,1.14 [0.76-1.71],0.5340380049394804
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14635,58,1.54 [1.04-2.27],0.029774896327502
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17720,144,1.10 [0.85-1.42],0.4830389423114196
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2127,103,1.08 [0.77-1.51],0.6511319250872898
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2263,265,0.87 [0.69-1.09],0.2115573052386647
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17658,82,1.09 [0.78-1.51],0.611701076115637
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2080,56,1.62 [1.17-2.23],0.0035763854657331
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19420,1844,1.00 [0.93-1.08],0.9932908117282704
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19476,274,0.98 [0.79-1.23],0.8718932508864489
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18306,196,1.04 [0.80-1.35],0.7690078800829928
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15208,631,1.00 [0.86-1.16],0.95659853877349
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19955,206,0.95 [0.73-1.24],0.6936433775720365
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19059,231,1.23 [0.99-1.54],0.0600513902973805
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,17657,1237,1.03 [0.92-1.14],0.635793731970768
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19155,327,1.17 [0.97-1.42],0.1017960471549429
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18893,65,0.85 [0.52-1.39],0.5104505186623209
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19017,189,1.00 [0.77-1.31],0.9823011335306654
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11762,1908,1.00 [0.92-1.09],0.9361726304490384
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,AV-block,16185,499,1.04 [0.88-1.22],0.6311166711181577
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20003,434,1.07 [0.90-1.27],0.4451056507872659
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiac arrest,10065,211,1.25 [1.02-1.53],0.0292988741991614
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15855,169,1.21 [0.93-1.57],0.1614530049031395
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15775,89,1.10 [0.75-1.61],0.6326983883539763
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20062,48,0.82 [0.47-1.41],0.4651989990017711
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,16809,1123,0.98 [0.87-1.09],0.6684248870294454
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18601,2201,1.02 [0.95-1.11],0.5437889313480002
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16981,6567,1.02 [0.97-1.06],0.4676599422693821
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19029,228,1.00 [0.78-1.28],0.97687928368638
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Endocarditis,15756,70,1.09 [0.71-1.65],0.7037352532814665
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19799,1104,1.10 [1.00-1.22],0.0612704759684187
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,17978,5704,1.03 [0.98-1.08],0.2473472754586857
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17983,5709,1.03 [0.98-1.08],0.2477121415271896
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19866,98,0.83 [0.56-1.23],0.3440863429506949
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12445,171,1.46 [1.18-1.80],0.0003886819702843
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12379,105,1.91 [1.60-2.27],3.404605595998759e-13
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,19939,994,1.04 [0.93-1.17],0.4761963580618759
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19183,97,0.80 [0.54-1.19],0.2744039181782934
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18716,2296,1.04 [0.96-1.12],0.3708158523254279
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19718,546,0.99 [0.85-1.16],0.9011191026684108
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16029,343,0.98 [0.80-1.19],0.808339516211614
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19478,895,1.04 [0.92-1.17],0.5367211102103415
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17196,776,1.09 [0.96-1.24],0.1735961300817579
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19925,194,1.20 [0.94-1.52],0.1492007410977139
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20019,315,0.91 [0.74-1.13],0.4014534839489685
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18855,54,1.26 [0.81-1.95],0.3135183383255324
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other aneurysm,18907,79,1.23 [0.84-1.79],0.2860493152840107
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,16090,404,1.15 [0.97-1.37],0.1083730907054108
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18935,107,0.97 [0.67-1.40],0.8564132477299556
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19051,223,1.20 [0.95-1.52],0.1186396552383071
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15842,156,0.80 [0.58-1.09],0.1616225046099432
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18878,77,0.97 [0.64-1.48],0.904646432823616
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18843,42,0.83 [0.45-1.52],0.5477198251653634
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18776,73,1.03 [0.67-1.57],0.8950241076877826
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18888,87,0.96 [0.65-1.43],0.853093019542116
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16716,1030,1.08 [0.96-1.20],0.195516288547701
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19000,55,1.12 [0.68-1.82],0.6607760840717232
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19296,468,1.04 [0.88-1.24],0.6187499874950815
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19521,320,1.20 [1.00-1.44],0.0512916162648694
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19242,539,1.09 [0.94-1.27],0.2716925320865264
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10163,309,1.06 [0.87-1.29],0.5398473084021596
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19214,429,1.05 [0.89-1.25],0.5556354133767887
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19093,292,0.91 [0.73-1.14],0.4101599700178447
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19611,410,1.16 [0.97-1.37],0.0974184708570179
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20011,589,1.22 [1.06-1.40],0.0046649005068304
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16082,396,0.99 [0.83-1.20],0.94881296684884
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19520,319,1.20 [1.00-1.43],0.0553494222599633
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18884,181,0.98 [0.74-1.29],0.8725729471347158
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19706,620,0.96 [0.83-1.11],0.5814411039394074
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19695,644,0.95 [0.82-1.10],0.4798640385716117
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19166,37,1.03 [0.57-1.89],0.9117165849180884
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18922,95,0.90 [0.60-1.34],0.5974471625656211
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19368,196,1.17 [0.92-1.50],0.2040914828170285
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18839,256,0.87 [0.68-1.10],0.2391164107643193
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,19120,319,0.94 [0.76-1.15],0.5404721009173366
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18844,59,0.97 [0.59-1.59],0.8953257421956886
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19855,641,1.01 [0.87-1.17],0.92039713224667
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19894,413,0.64 [0.52-0.78],1.03774734660138e-05
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17303,810,1.03 [0.90-1.17],0.6768705527059824
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,19483,2990,0.97 [0.90-1.04],0.3866013923043863
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19842,481,0.67 [0.56-0.81],2.9329777248742035e-05
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17450,957,1.06 [0.94-1.20],0.334328423237443
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16554,61,1.08 [0.67-1.74],0.754064636064386
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,19506,1285,0.95 [0.85-1.05],0.3087390005638313
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18047,1554,0.89 [0.80-0.98],0.02337516212578
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Vascular dementia,19678,116,0.84 [0.58-1.20],0.3334898243830791
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Alzheimer disease,20062,244,0.84 [0.66-1.08],0.171616070855307
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13445,49,0.52 [0.29-0.92],0.0245097335542165
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Bell's palsy,18916,67,1.16 [0.75-1.78],0.5088058135520789
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19138,289,0.99 [0.80-1.24],0.9625713118100788
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral cysts,19729,188,1.06 [0.81-1.38],0.6895348185904793
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19990,287,0.94 [0.75-1.18],0.6043665601546879
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19659,55,0.98 [0.60-1.62],0.9444314678497318
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20047,66,1.05 [0.67-1.64],0.8366430662494586
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19615,74,0.78 [0.49-1.23],0.2840442624347492
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,18728,232,0.87 [0.68-1.13],0.2995555796676398
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19617,1121,1.14 [1.02-1.26],0.0184108402811788
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20029,395,0.88 [0.72-1.06],0.1835706076136881
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19602,1774,1.00 [0.91-1.09],0.9877032690837712
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19742,47,1.04 [0.60-1.80],0.8847937028761148
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,19926,223,0.91 [0.70-1.18],0.4706854932610382
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hydrocephalus,19590,49,1.05 [0.62-1.77],0.8545316996615816
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20047,53,1.05 [0.64-1.74],0.8473688098655598
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18868,19,1.01 [0.43-2.39],0.9761736092583532
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18926,77,0.98 [0.64-1.51],0.9402089471746078
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Memory loss,19547,105,0.98 [0.68-1.41],0.9084300104296984
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,18657,161,1.54 [1.23-1.94],0.0002256534447943
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20044,147,1.57 [1.24-2.00],0.0001848582135594
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Motor neuron disease,13547,139,1.18 [0.87-1.60],0.2775049178395822
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19960,59,1.60 [1.08-2.37],0.0181785130822892
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19660,811,1.03 [0.90-1.17],0.6919833434889968
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,18949,2956,1.03 [0.96-1.10],0.4748241339048612
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19788,184,0.80 [0.60-1.07],0.1368532166630215
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19159,310,1.08 [0.87-1.32],0.4943996632425357
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19987,296,1.08 [0.88-1.33],0.4523811312373217
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15854,508,0.93 [0.79-1.10],0.4064946682833891
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19601,60,1.17 [0.75-1.82],0.4994381621076836
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19666,125,0.81 [0.57-1.15],0.2330069555612655
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19742,108,1.32 [0.97-1.80],0.0750792918687489
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18933,84,1.19 [0.81-1.74],0.3805154778683474
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other headache syndromes,18530,34,1.24 [0.70-2.18],0.4669412774775339
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,19965,424,1.01 [0.84-1.21],0.9343834421057384
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,19073,577,1.16 [1.00-1.34],0.0493596543718282
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Parkinson's disease,20041,267,0.75 [0.59-0.96],0.020989366917067
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19563,22,1.54 [0.82-2.91],0.1791969317866769
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Restless leg syndrome,20061,36,0.98 [0.53-1.84],0.961170431621822
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,19817,523,1.14 [0.98-1.33],0.0877628899360466
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19740,49,1.45 [0.95-2.21],0.084260259961522
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20045,158,1.18 [0.89-1.55],0.2578084603908589
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18877,28,0.84 [0.40-1.77],0.6495451444019884
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20062,247,0.82 [0.64-1.06],0.125119013459647
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19650,112,0.84 [0.58-1.21],0.3444871059470079
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19621,69,1.46 [1.02-2.09],0.038262712614125
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19770,240,1.09 [0.87-1.36],0.4784990609790633
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19912,247,0.79 [0.62-1.00],0.0483528856096169
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19322,40,0.74 [0.39-1.38],0.3400685319911421
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19336,54,1.04 [0.63-1.72],0.8818468205294696
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19984,34,0.75 [0.38-1.46],0.3923293471083394
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19876,101,1.04 [0.73-1.48],0.8329797041101002
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2080,56,1.64 [1.19-2.25],0.0023984196832145
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2534,108,1.07 [0.77-1.49],0.6722349975747031
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19632,80,1.05 [0.70-1.59],0.7994808034825867
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19874,842,0.96 [0.85-1.09],0.5656504782382221
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19804,522,1.02 [0.87-1.20],0.7969067405248254
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19394,112,1.10 [0.79-1.52],0.5702577104151763
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19999,469,1.19 [1.02-1.40],0.0283744351209485
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20060,55,1.17 [0.73-1.87],0.5050804763188496
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19947,417,1.19 [1.01-1.41],0.0422409878374238
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20030,255,0.85 [0.67-1.08],0.1881493323280449
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19986,132,1.05 [0.76-1.44],0.7721081953398268
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19348,66,1.17 [0.77-1.77],0.4701133160307528
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19358,76,0.77 [0.49-1.22],0.2699015502931
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19316,34,1.09 [0.61-1.97],0.7684277422256303
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19982,571,1.00 [0.86-1.16],0.9780440195528
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19575,164,0.80 [0.59-1.08],0.1445107245468752
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19553,23,1.09 [0.52-2.28],0.818913742013072
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19856,81,0.73 [0.47-1.13],0.1624439689925014
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19954,179,0.94 [0.71-1.24],0.6704086110558818
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19679,149,1.45 [1.13-1.87],0.003847373389778
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19924,70,1.11 [0.72-1.69],0.6402148512888914
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19782,371,0.98 [0.81-1.18],0.8157120755170418
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19650,98,1.17 [0.83-1.65],0.3725715285710864
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18934,1493,1.00 [0.91-1.10],0.962826608696385
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19930,155,0.92 [0.68-1.24],0.5883647774804669
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20047,119,0.99 [0.71-1.38],0.9421681938324052
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19647,365,0.95 [0.78-1.15],0.5890514959326488
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19833,58,0.76 [0.45-1.27],0.2989540463783108
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20050,45,1.16 [0.69-1.95],0.5778044611975579
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19342,60,1.22 [0.79-1.89],0.3615586706748726
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19409,127,1.11 [0.81-1.52],0.5248132010685419
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19138,106,0.79 [0.54-1.15],0.2124861973923456
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19567,37,1.43 [0.88-2.32],0.145252430762283
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19087,55,0.88 [0.52-1.48],0.625734381652949
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19452,41,0.90 [0.49-1.65],0.736401524728955
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19582,171,0.97 [0.74-1.29],0.8588932673718036
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19379,97,0.92 [0.63-1.34],0.6693750488631351
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19139,107,1.12 [0.79-1.59],0.533703914093853
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19107,75,0.98 [0.64-1.49],0.9074017432822208
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18640,1199,1.02 [0.92-1.14],0.6491440174417601
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19328,46,0.70 [0.39-1.24],0.2214626910304075
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19867,315,1.14 [0.93-1.38],0.2067870712399275
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19612,60,0.93 [0.57-1.52],0.7852591027790725
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19674,122,1.12 [0.81-1.54],0.4998712979357133
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19908,52,1.13 [0.70-1.83],0.6067323273761642
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20026,108,1.03 [0.72-1.48],0.8660444973928125
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19947,95,1.04 [0.71-1.52],0.8333904652904214
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19901,45,0.84 [0.47-1.51],0.5701852466354798
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19898,42,1.40 [0.88-2.21],0.1564585528396184
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19977,785,0.96 [0.84-1.10],0.5390121388227673
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19774,582,0.94 [0.80-1.10],0.4260642115460697
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19299,107,0.95 [0.66-1.36],0.7824077336258151
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19262,70,0.88 [0.55-1.39],0.5754237409836935
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19876,46,1.58 [1.03-2.42],0.034428206823788
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19988,158,1.25 [0.96-1.63],0.1035395515867566
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19882,52,1.14 [0.71-1.83],0.5833762344601766
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza,18176,85,1.17 [0.80-1.72],0.4199607193065012
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18173,82,1.20 [0.81-1.76],0.3621274052440603
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13162,86,1.50 [1.09-2.07],0.0139035613745318
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19974,229,0.86 [0.66-1.11],0.2458369549061536
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14001,1214,1.03 [0.92-1.14],0.6381578504680401
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14266,1190,1.03 [0.92-1.15],0.6001107979383542
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19729,123,1.41 [1.07-1.86],0.0148373856179864
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18166,75,1.59 [1.15-2.19],0.0045806517028134
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bronchiectasis,17421,244,1.09 [0.87-1.37],0.4483786924071559
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17213,36,1.51 [0.93-2.46],0.0948281491178657
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19337,2160,1.05 [0.97-1.14],0.2141995576587398
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18829,66,1.05 [0.66-1.65],0.8472133915383326
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18891,128,1.40 [1.06-1.85],0.0178039428545717
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19873,1096,0.95 [0.85-1.07],0.3907888532251247
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18887,124,1.17 [0.84-1.61],0.3506036724654235
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18357,4405,1.06 [1.00-1.11],0.054278600940762
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19102,339,1.22 [1.01-1.47],0.0402074658500332
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,19047,270,0.98 [0.77-1.23],0.8483513369848357
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Emphysema,17484,307,1.12 [0.91-1.39],0.2916680850889089
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19263,301,0.99 [0.80-1.23],0.9288581528997216
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19853,1762,1.10 [1.01-1.20],0.0231678494853184
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19285,323,1.06 [0.87-1.30],0.5601393644279569
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Later onset COPD,19123,826,0.93 [0.82-1.07],0.3170641388578704
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20046,331,0.95 [0.77-1.17],0.5993845355948753
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,18894,131,1.33 [1.00-1.77],0.0491346400687034
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19829,813,1.09 [0.96-1.23],0.1985786283296791
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19829,1836,1.13 [1.05-1.23],0.002571485387642
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19506,743,1.07 [0.93-1.22],0.3390064871217149
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other pleural conditions,18043,50,1.15 [0.70-1.90],0.5811927212914829
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19967,392,1.11 [0.93-1.32],0.2573729629218234
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19960,1170,1.16 [1.05-1.29],0.0042249838615932
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,18918,925,1.17 [1.04-1.31],0.0069444127962944
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural plaque,18217,224,1.00 [0.78-1.28],0.9880252737743976
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19641,1550,1.12 [1.03-1.23],0.011385670911766
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19960,245,0.96 [0.75-1.22],0.7387264866560639
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumothorax,18113,120,1.36 [1.02-1.82],0.038771268491655
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pollen allergy,20048,198,0.86 [0.65-1.13],0.2775859512319086
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19631,56,1.11 [0.70-1.75],0.6506026546493541
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13127,51,1.05 [0.63-1.75],0.84866259461113
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19813,797,1.09 [0.96-1.24],0.1724139992053117
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18993,230,0.86 [0.66-1.11],0.2419600415179083
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Viral pneumonia,18314,223,1.08 [0.85-1.37],0.5409399949238136
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19749,190,1.06 [0.82-1.38],0.6392222202733147
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8788,96,1.27 [0.89-1.80],0.1889577149904025
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14060,72,1.34 [0.92-1.97],0.1317907930748716
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,19951,118,1.02 [0.72-1.45],0.8916576328661319
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute gastritis,15201,71,1.08 [0.71-1.63],0.723896855511903
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18910,173,0.95 [0.71-1.27],0.7310745025405883
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute peritonitis,19754,78,0.80 [0.51-1.25],0.3225918340947669
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19303,94,0.80 [0.53-1.20],0.2783843280652315
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Barrett oesophagus,15573,443,0.95 [0.80-1.14],0.606110683241345
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18839,102,1.12 [0.79-1.58],0.5248022054164041
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19721,102,1.11 [0.78-1.58],0.5532819389418118
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,18922,185,1.16 [0.90-1.49],0.2575306875060343
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,19422,685,1.24 [1.09-1.40],0.0010902405037322
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,15350,220,0.97 [0.75-1.24],0.7879985999961091
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18784,47,0.72 [0.40-1.29],0.2654265217777805
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19887,119,1.06 [0.77-1.46],0.7290469066622749
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,18696,74,1.37 [0.95-1.99],0.0945676746153782
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Collagenous colitis,18848,40,1.11 [0.62-1.98],0.7221129808614182
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19920,183,0.95 [0.72-1.26],0.7324883531788488
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,19921,1295,0.92 [0.83-1.03],0.1450810728777451
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,18884,76,1.38 [0.96-1.99],0.083309120216694
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19770,55,1.02 [0.62-1.69],0.930730670030168
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18872,64,1.42 [0.96-2.10],0.0819319731674384
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,19521,184,1.15 [0.88-1.49],0.312086122806704
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17005,1627,1.02 [0.93-1.12],0.649658174302633
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,19976,143,1.00 [0.73-1.38],0.987532331544976
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,19943,734,1.01 [0.88-1.15],0.9022214745149948
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18372,3242,1.03 [0.97-1.10],0.3749192313214765
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19756,419,1.00 [0.83-1.20],0.998936172964243
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20024,348,1.15 [0.96-1.39],0.1300416410278639
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19424,87,1.18 [0.81-1.72],0.3941044630470608
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19314,51,1.11 [0.67-1.85],0.6792070555420889
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19797,1175,1.06 [0.95-1.18],0.2701008576927507
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of tongue,19323,93,1.18 [0.82-1.71],0.3706450015932565
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19766,1029,1.13 [1.01-1.26],0.028396876745028
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16550,2562,1.07 [1.00-1.15],0.0486349439627297
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15344,214,1.10 [0.86-1.40],0.4678471625727264
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19961,166,0.96 [0.72-1.29],0.7824909759302899
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20005,34,0.60 [0.30-1.22],0.157209970226555
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19346,137,1.06 [0.78-1.43],0.7252821296713561
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14136,148,1.07 [0.80-1.42],0.6652507230535263
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15481,351,0.93 [0.76-1.14],0.5041967470185202
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,15435,305,1.12 [0.92-1.37],0.2492619503120729
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16924,1794,1.03 [0.95-1.12],0.4872884481315803
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15619,489,1.12 [0.96-1.31],0.151713236901242
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15344,6675,1.02 [0.97-1.07],0.4405699628256414
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,19594,972,1.06 [0.95-1.20],0.2964621717801885
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19381,44,0.96 [0.54-1.70],0.8854827975449879
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14769,1014,1.11 [0.99-1.25],0.0611966354653914
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19280,71,0.66 [0.41-1.06],0.0829991551083043
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,18331,2953,1.02 [0.95-1.09],0.5802320754421766
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,20008,33,0.66 [0.33-1.35],0.2555882267666208
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impaction of intestines,14026,38,1.03 [0.57-1.87],0.9194733246222244
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,16752,1374,1.03 [0.93-1.14],0.5826357969513098
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15541,163,0.93 [0.69-1.26],0.6486700201152115
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14063,75,1.08 [0.72-1.64],0.70321871655575
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18709,87,1.31 [0.91-1.86],0.1421624150563611
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14223,235,1.12 [0.89-1.42],0.3301985277577256
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20025,315,0.94 [0.76-1.16],0.5464314563738625
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19374,566,1.09 [0.93-1.27],0.2785700982293257
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19552,744,1.09 [0.95-1.24],0.2054379843894295
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15304,174,1.10 [0.83-1.44],0.5090333303231016
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,15656,526,1.11 [0.95-1.29],0.1994146025301648
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20014,94,0.96 [0.65-1.42],0.8285375527320533
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15435,57,0.91 [0.55-1.50],0.7061853176055692
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15188,1200,0.98 [0.88-1.10],0.7813092129928277
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18954,217,0.96 [0.74-1.24],0.7653677186331114
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18840,103,1.11 [0.78-1.58],0.5538337076822484
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15568,1580,1.09 [1.00-1.19],0.0593086807653269
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18523,4535,1.01 [0.96-1.07],0.6207321547800736
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19294,153,0.94 [0.69-1.28],0.6840078900284583
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,19798,589,1.00 [0.86-1.17],0.9567499893303976
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15750,620,0.99 [0.85-1.15],0.922499855668766
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18850,113,0.95 [0.67-1.35],0.7603182140782141
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19967,291,1.22 [1.00-1.48],0.0529910780726422
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15793,663,1.07 [0.93-1.23],0.3384268524939219
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19603,981,1.06 [0.94-1.19],0.3247214573082155
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19482,145,1.05 [0.77-1.42],0.7678380807959729
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15313,1325,0.94 [0.85-1.04],0.2391576643648669
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16696,1566,1.01 [0.92-1.10],0.9120042187326792
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19289,80,1.02 [0.69-1.52],0.903223774636849
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19457,649,1.07 [0.93-1.24],0.3368266056434489
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14279,291,1.06 [0.86-1.31],0.589333232867655
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19996,42,0.77 [0.41-1.43],0.4018009301158303
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14382,394,1.09 [0.91-1.31],0.3402375968382459
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18764,142,0.87 [0.62-1.21],0.3949168132174711
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20048,34,0.95 [0.50-1.80],0.8717588639003264
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19342,80,0.99 [0.65-1.51],0.9554472869514566
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Toxic colitis,18846,38,1.23 [0.73-2.10],0.4388570336574886
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15388,258,1.00 [0.80-1.27],0.9789306918502156
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18934,126,1.27 [0.94-1.71],0.1176309729189038
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18912,104,1.26 [0.90-1.76],0.1824712252406131
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,15678,300,1.00 [0.81-1.24],0.9818092854906736
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14119,131,0.94 [0.68-1.31],0.7303231667347572
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,15594,216,1.15 [0.90-1.46],0.2667947397402229
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Volvulus,14046,58,1.28 [0.84-1.97],0.2555563622749483
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20008,273,1.11 [0.89-1.38],0.3446424113851065
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19799,58,0.98 [0.60-1.60],0.9217234068847642
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18430,76,0.90 [0.57-1.40],0.6344433080137557
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19439,639,1.06 [0.92-1.22],0.4476885281266719
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18970,170,0.98 [0.73-1.30],0.8651846833046988
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18718,364,1.23 [1.04-1.47],0.0174687171562619
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19818,225,1.00 [0.78-1.28],0.9878781769116122
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19979,386,0.92 [0.76-1.11],0.3886966826693715
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19631,38,1.26 [0.73-2.17],0.4119976367096585
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18799,2623,1.02 [0.95-1.10],0.5295948366522856
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19675,335,0.89 [0.72-1.09],0.2600582555416921
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19577,237,0.86 [0.67-1.11],0.2517246741742002
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19664,864,1.05 [0.93-1.19],0.406998435824657
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20052,24,0.77 [0.35-1.71],0.5218714182786971
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18376,22,0.46 [0.19-1.10],0.0815831761786893
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19392,52,1.14 [0.71-1.84],0.580812210710397
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19814,221,1.00 [0.78-1.28],0.9760328247597988
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18752,398,1.02 [0.85-1.23],0.813121694269386
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18420,66,1.09 [0.70-1.70],0.6914400941327712
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20005,71,1.11 [0.73-1.69],0.6276576734041619
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18966,166,0.93 [0.69-1.24],0.602478737531212
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19921,180,0.88 [0.66-1.17],0.3856287104057252
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19651,58,0.81 [0.49-1.36],0.4346820845865782
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18407,53,1.27 [0.80-2.01],0.3050070437714925
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19678,1324,1.04 [0.94-1.15],0.4389537433562686
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18787,433,1.06 [0.89-1.26],0.5352040610963641
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18423,69,0.94 [0.60-1.49],0.8076744599098139
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19987,246,0.92 [0.72-1.17],0.4950077247176031
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19636,43,0.66 [0.36-1.21],0.177294990664601
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19957,216,0.93 [0.71-1.20],0.5660089207455475
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20024,289,1.12 [0.91-1.38],0.281445509271098
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18426,72,0.95 [0.61-1.49],0.8263689437736594
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18575,221,0.79 [0.61-1.04],0.0894777794833541
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20018,283,1.11 [0.90-1.37],0.3290053662642019
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18562,208,1.07 [0.83-1.37],0.616769093294657
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20039,105,1.15 [0.82-1.62],0.4131773916509909
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17303,69,0.77 [0.48-1.22],0.2682745580726701
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18300,3987,1.02 [0.96-1.08],0.487681359785972
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17115,2802,0.98 [0.92-1.05],0.59919193963788
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17297,63,0.45 [0.27-0.75],0.002289713774798
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17655,119,1.03 [0.73-1.45],0.8639321265426627
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17653,117,1.00 [0.71-1.41],0.9867816351856328
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19890,54,0.78 [0.46-1.34],0.3758930604086398
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17599,63,0.55 [0.33-0.93],0.0258547168918548
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15041,728,1.00 [0.87-1.14],0.9844907592456784
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19962,124,1.09 [0.79-1.51],0.598104851695886
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17755,219,1.15 [0.91-1.45],0.2444066486913016
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17078,5227,1.02 [0.97-1.08],0.3989487594278387
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19193,85,0.71 [0.46-1.10],0.1292846901248081
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17370,136,1.16 [0.87-1.55],0.3222577774583927
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17610,376,0.97 [0.80-1.18],0.7610698071654651
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19366,1830,0.97 [0.89-1.06],0.4541979050674318
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17550,316,0.95 [0.77-1.18],0.6377030005133095
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17279,45,1.38 [0.85-2.23],0.1960252483017459
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17315,81,1.02 [0.67-1.54],0.9265690953981444
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19792,26,0.85 [0.40-1.80],0.6702072040088831
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15518,1205,1.00 [0.90-1.10],0.9456989258085984
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15121,808,1.15 [1.03-1.29],0.0147991650975569
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19942,796,1.18 [1.05-1.32],0.0063828490701621
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14351,38,0.77 [0.41-1.47],0.4354781724469375
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14380,67,1.12 [0.74-1.71],0.5937969883531613
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17452,218,0.87 [0.67-1.13],0.2998892109307683
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14840,527,1.06 [0.91-1.24],0.4353749876492663
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17570,34,1.59 [0.98-2.60],0.0622398476602482
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17972,436,0.90 [0.75-1.08],0.2488087015844898
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17751,215,0.93 [0.72-1.20],0.5748839928199092
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14804,491,1.06 [0.90-1.24],0.5006612932748005
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17287,53,1.64 [1.15-2.35],0.0067526551253439
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17275,41,0.67 [0.36-1.26],0.2150153575885586
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19185,77,1.00 [0.67-1.49],0.9897864361818964
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19822,714,0.89 [0.77-1.03],0.1056579012720687
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19434,326,0.93 [0.75-1.15],0.5011970660699039
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19997,244,1.04 [0.83-1.32],0.7198401911324162
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15868,1555,0.99 [0.91-1.09],0.8705259571201125
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14359,46,0.61 [0.33-1.11],0.1033034502453127
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17299,65,0.95 [0.59-1.53],0.8467934681008564
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14359,46,0.84 [0.48-1.48],0.5463427339847571
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14351,38,0.64 [0.33-1.23],0.1822588417214106
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19261,153,0.80 [0.58-1.10],0.1644685668328007
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19245,137,0.96 [0.69-1.33],0.7981669178933912
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20033,69,1.00 [0.64-1.56],0.9996834929416616
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18794,1258,1.02 [0.92-1.13],0.7622759907130975
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17287,53,0.64 [0.37-1.11],0.1085604052844949
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14348,35,0.75 [0.38-1.46],0.3892958916069032
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18051,515,0.93 [0.79-1.10],0.3793098630785479
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15736,1423,1.02 [0.93-1.12],0.6492624387039422
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19811,45,0.81 [0.45-1.46],0.4867274233342535
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20049,52,0.94 [0.56-1.59],0.8291871129611025
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17304,70,0.75 [0.47-1.21],0.2402309756140283
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18052,818,1.04 [0.91-1.18],0.5716158246606486
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17311,77,1.26 [0.87-1.82],0.2296672425256243
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15334,1021,1.07 [0.96-1.20],0.2046806952874957
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19178,70,0.95 [0.60-1.50],0.830216747265629
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17272,38,0.88 [0.47-1.66],0.6943255543023008
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17628,92,0.65 [0.43-0.99],0.0442404852113968
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17651,417,1.01 [0.84-1.21],0.9139468166310272
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19925,159,1.01 [0.75-1.35],0.9642693313113628
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17941,405,1.03 [0.86-1.24],0.7312794430949534
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20005,241,1.05 [0.83-1.33],0.6742037678742471
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20049,31,1.36 [0.79-2.37],0.2702767248751375
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17363,129,1.03 [0.74-1.42],0.8738921142557934
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16466,473,0.91 [0.77-1.08],0.276923059130049
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17632,398,0.97 [0.81-1.17],0.7465074340341313
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17520,286,0.90 [0.72-1.13],0.3617776141632046
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14338,25,0.81 [0.37-1.76],0.5910065513558473
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16210,1897,1.08 [0.99-1.17],0.068573702325255
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14676,363,0.97 [0.81-1.18],0.777337582015058
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19898,132,1.02 [0.74-1.40],0.9142869210196728
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20001,37,0.72 [0.37-1.39],0.3268967622577296
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18419,35,1.10 [0.65-1.87],0.7328168614861376
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14367,54,0.93 [0.57-1.55],0.7933625139502863
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17609,73,1.06 [0.70-1.61],0.783045187010002
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14564,251,1.03 [0.82-1.28],0.8192474240082185
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17476,242,0.94 [0.74-1.20],0.6181170739444632
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17713,177,1.18 [0.92-1.52],0.2023012301901662
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17606,70,0.91 [0.58-1.43],0.6906275118931158
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15953,25,1.19 [0.61-2.33],0.6079188541373555
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20051,33,1.19 [0.66-2.15],0.5695357671493644
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17675,441,0.84 [0.70-1.01],0.0640630738002645
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19783,17,0.70 [0.27-1.84],0.4715144093962131
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19149,1915,0.98 [0.90-1.06],0.5944632569206495
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17323,89,1.00 [0.67-1.49],0.9999211666467582
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17942,406,0.93 [0.78-1.12],0.4573752874323415
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19156,165,0.86 [0.64-1.17],0.3399702485207073
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17653,117,1.13 [0.82-1.55],0.4555738728035361
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18611,1075,0.94 [0.84-1.05],0.2937124915784134
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18204,668,0.94 [0.81-1.08],0.3836153315159399
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17265,31,1.32 [0.74-2.38],0.348081916886241
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19802,36,1.28 [0.73-2.27],0.3902677510595412
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17341,107,0.97 [0.67-1.39],0.8470298254864101
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17253,19,1.01 [0.43-2.38],0.9824539148747392
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14364,51,1.09 [0.66-1.80],0.7372250426986817
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19321,1499,1.24 [1.14-1.35],5.883898623519283e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19670,334,1.09 [0.90-1.33],0.3852062538167505
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19457,121,1.21 [0.89-1.64],0.2175379120463371
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18946,1124,1.49 [1.38-1.62],1.3369179335456713e-21
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19864,46,2.00 [1.52-2.63],6.450590906977288e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19853,282,1.31 [1.09-1.57],0.0042139442117331
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,17716,172,0.99 [0.74-1.32],0.9233210820570724
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dialysis,17890,68,2.32 [1.91-2.82],2.4551927520663272e-17
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19012,2770,1.18 [1.11-1.26],9.244349424085284e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18139,4642,1.16 [1.10-1.23],1.4488396073993173e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19888,70,1.38 [1.00-1.92],0.0521071870957185
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16411,169,1.17 [0.89-1.55],0.2558131625404298
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17886,287,1.19 [0.97-1.47],0.0874594036785148
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18415,2173,1.23 [1.14-1.33],3.775632827332846e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16435,193,1.40 [1.11-1.77],0.0046287620673882
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17602,58,0.98 [0.59-1.62],0.9260548984410966
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16342,100,1.33 [0.95-1.87],0.0947533525615763
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20055,52,0.76 [0.44-1.32],0.3315643260466214
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20053,44,0.95 [0.53-1.68],0.8539441087103528
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19368,1824,1.06 [0.97-1.15],0.1776599605775837
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18341,797,1.00 [0.87-1.14],0.956702083194656
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20004,433,1.31 [1.13-1.52],0.000445979066066
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16499,257,1.17 [0.93-1.47],0.1778282570938412
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16477,235,0.87 [0.68-1.13],0.3021369250721054
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16430,188,1.29 [1.00-1.65],0.0457852120075573
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20051,41,1.38 [0.87-2.20],0.1764589787984223
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18764,1220,1.09 [0.99-1.21],0.0843347852367396
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17920,321,1.14 [0.94-1.39],0.1906720894938134
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19717,146,1.20 [0.91-1.59],0.2007810740104091
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19870,52,1.36 [0.88-2.10],0.1606052610374092
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16463,221,1.17 [0.92-1.49],0.204182091519463
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19844,2245,1.24 [1.15-1.33],2.312172457291985e-09
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17654,55,1.09 [0.67-1.78],0.7155627517662067
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17936,114,1.67 [1.30-2.15],6.195778727086795e-05
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19398,62,0.79 [0.48-1.30],0.3522805688380637
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17789,245,1.07 [0.85-1.35],0.5625854951744702
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19773,437,1.09 [0.92-1.30],0.3092740560706176
